Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05641324
Title	A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Anaveon AG
Indications	multiple myeloma
Therapies	ANV419 + Dexamethasone + Lenalidomide ANV419 + Daratumumab ANV419
Age Groups:	adult \| senior
Covered Countries	FRA \| ESP \| DNK \| DEU \| CHE

Filter rows:

Showing 1 to 11 of 11 entries

Facility	City	Zip	Country	Details
CHU de Nantes - Hôtel-Dieu	Nantes		France	Details
Hospital Clinic Barcelona	Barcelona		Spain	Details
Hospital Clinico Universitario de Salamanca	Salamanca		Spain	Details
Hospital General Universitario Morales Meseguer	Murcia		Spain	Details
Hospital Universitario La Princesa	Madrid	28006	Spain	Details
Inselspital, Universitätsspital Bern	Bern		Switzerland	Details
Institut de cancérologie Strasbourg Europe (ICANS)	Strasbourg		France	Details
Institut Paoli-Calmettes	Marseille		France	Details
Kantonsspital St. Gallen	Saint Gallen		Switzerland	Details
Universitätsklinikum Jena	Jena	07747	Germany	Details
Vejle Hospital	Vejle		Denmark	Details

Showing 1 to 11 of 11 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field